Inovio Pharmaceuticals Inc vs Victoria's Secret & Co — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Victoria's Secret & Co trades at $87.75 (market cap $6.95B). The key difference: Victoria's Secret & Co is far larger — about 77.9× Inovio Pharmaceuticals Inc's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | VSXY | |
|---|---|---|
Market Cap | $89.27M | $6.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $88.50 |
52-Week Low | $1.05 | $18.72 |
Enterprise Value | $60.28M | $9.59B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →